Valuation: PharmGen Science, Inc.

Market Cap 91.05B 68.29M 60.7M 56.26M 51.19M 96.6M 6.48B 98.15M 676M 265M 3.38B 256M 251M 10.78B P/E 2023
20.2x
P/E 2024 26.9x
Enterprise Value 91.59B 68.7M 61.06M 56.6M 51.49M 97.17M 6.52B 98.73M 680M 267M 3.4B 258M 252M 10.85B EV / Sales 2023
0.67x
EV / Sales 2024 0.44x
Free-Float
76.72%
Yield 2023 *
-
Yield 2024 -
25-05-15 PharmGen Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-03-21 PharmGen Science, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
24-11-14 PharmGen Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
23-09-18 PharmGen Science, Inc.(KOSE:A004720) dropped from S&P Global BMI Index CI
23-05-15 PharmGen Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
22-03-10 PharmGen Science Inc. announced that it has received KRW 20 billion in funding from Meritz Securities Co., Ltd. CI
22-03-02 PharmGen Science Inc. announced that it expects to receive KRW 20 billion in funding from Meritz Securities Co., Ltd. CI
21-06-10 PharmGen Science Inc. announced that it has received KRW 30 billion in funding from Linden Advisors LP, SC Lowy Financial (HK) Limited CI
21-05-16 PharmGen Science Inc. announced that it expects to receive KRW 30 billion in funding from Linden Advisors LP, SC Lowy Financial (HK) Limited CI
20-11-26 Wooridul Pharmaceutical Limited announced that it has received KRW 20 billion in funding from Linden Advisors LP, SC Lowy Financial (HK) Limited CI
20-11-10 Wooridul Pharmaceutical Limited announced that it expects to receive KRW 20 billion in funding from Linden Advisors LP, SC Lowy Financial (HK) Limited CI
20-09-21 Wooridul Pharmaceutical Limited(KOSE:A004720) added to S&P Global BMI Index CI
20-07-02 Wooridul Pharmaceutical Limited cancelled the acquisition of 11.6% stake in Access Bio, Inc. from Youngho Choi. CI
1 day+2.02%
1 week-2.97%
Current month-3.81%
1 month-2.63%
3 months-18.38%
6 months-30.28%
Current year-33.21%
1 week 2,690
Extreme 2690
2,875
1 month 2,690
Extreme 2690
2,985
Current year 2,590
Extreme 2590
4,485
1 year 2,590
Extreme 2590
4,485
3 years 2,590
Extreme 2590
7,130
5 years 2,590
Extreme 2590
13,450
10 years 2,590
Extreme 2590
33,650
Manager TitleAgeSince
Chief Executive Officer 58 2019-03-26
Chief Executive Officer 69 -
Comptroller/Controller/Auditor 60 -
Director TitleAgeSince
Director/Board Member 60 -
Director/Board Member 69 -
Director/Board Member 58 2019-03-26
Date Insider Type Main position Quantity % Market Cap. Importance
4/14/25 Free 2,260 0.0124%
4/14/25 Free 209 0.0011%
4/14/25 Free 209 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
+2.02%-2.97%-31.57%-51.99% 47.07M
+0.43%+6.59%+56.57%+107.01% 1,120B
+0.90%-2.25%+32.26%+67.33% 616B
+0.71%+3.24%+24.33%+91.20% 504B
-0.13%+5.98%+33.66%+52.01% 367B
+0.52%+0.24%+72.13%+43.10% 360B
-0.95%+4.70%+19.65%+43.09% 288B
-1.98%+3.73%-0.89%+17.28% 258B
-0.35%+4.25%+44.74%+52.51% 234B
-0.75%+3.32%+27.18%+96.05% 194B
Average +0.04%+2.77%+27.81%+51.76% 394.09B
Weighted average by Cap. +0.13%+3.52%+39.34%+73.51%

Financials

2023 2024
Net sales 167B 125M 111M 103M 93.77M 177M 11.87B 180M 1.24B 486M 6.2B 469M 459M 19.75B 171B 128M 114M 106M 96.31M 182M 12.19B 185M 1.27B 499M 6.36B 482M 472M 20.28B
Net income 5.73B 4.3M 3.82M 3.54M 3.22M 6.08M 408M 6.17M 42.54M 16.68M 213M 16.12M 15.78M 678M 2.79B 2.09M 1.86M 1.72M 1.57M 2.96M 199M 3.01M 20.73M 8.13M 104M 7.86M 7.69M 330M
Net Debt 526M 395K 351K 325K 296K 558K 37.45M 567K 3.91M 1.53M 19.54M 1.48M 1.45M 62.3M 540M 405K 360K 334K 304K 573K 38.45M 582K 4.01M 1.57M 20.07M 1.52M 1.49M 63.97M
Projected Income Statement - Annual - PharmGen Science, Inc.
Logo PharmGen Science, Inc.
PharmGen Science Inc, formerly Wooridul Pharmaceutical Ltd, is a Korea-based company principally engaged in the manufacturing and distribution of pharmaceuticals. The Company’s products include antiepileptic agents, anti-inflammatory agents, antiphlogistic agents, central nervous system agents, urinary agents, antihistamine agents, antivirus agents, agents for bones, agents for livers, calcium agents, antibiotics, diabetes agents, respiratory agents, as well as over-the-counter (OTC) drugs, obesity drugs, health food and others. In addition, the Company is also engaged in the manufacturing, wholesale and retail distribution of functional cosmetics. The Company distributes its products within domestic market and to overseas markets.
Employees
226
Date Price Change Volume
26-10-16 ₩2,775.00 +2.02% 12,806
26-10-15 ₩2,720.00 -3.20% 13,126
26-10-14 ₩2,810.00 +0.90% 16,544
26-10-13 ₩2,785.00 -1.76% 33,352
  1. Stock Market
  2. Stocks
  3. A004720 Stock